Related content

CpG Island Methylator Phenotype Associated with Tumor Recurrence in Tumor–Node–Metastasis Stage I Hepatocellular Carcinoma

By Li Binkui   Liu Wenji   Wang Li   Li Meixiang   Wang Jianping   Huang Liang   Huang Pinzhu   Yuan Yunfei  

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1917-1926

Springer Publishing Company

Access to resources Recommend Favorite

Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity

By Alteber Zoya   Azulay Meir   Cafri Gal   Vadai Ezra   Tzehoval Esther   Eisenbach Lea  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 369-380

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of human adenocarcinoma with CpG-ODN in a mouse model

By          

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1061-1063

Spandidos Publications

Access to resources Recommend Favorite

CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2–specific T lymphocytes but do not lead to a protective tumor-specific memory response

By Sfondrini Lucia   Besusso Dario   Bronte Vincenzo   Macino Beatrice   Rossini Anna   Colombo Mario   Ménard Sylvie   Balsari Andrea  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 697-704

Springer Publishing Company

Access to resources Recommend Favorite

Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells

By Pilon-Thomas Shari   Verhaegen Monique   Kuhn Lisa   Riker Adam   Mulé James  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1238-1246

Springer Publishing Company

Access to resources Recommend Favorite